October 16, 2018 / 5:21 AM / a month ago

BRIEF-Novartis says 5-year data reinforce cosentyx leadership in spondyloarthritis

Oct 16 (Reuters) - Novartis AG:

* NOVARTIS 5-YEAR DATA IN PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS REINFORCES COSENTYX® LEADERSHIP IN SPONDYLOARTHRITIS Source text for Eikon: Further company coverage: (Reporting By Zurich newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below